143,057 members

Skip to content. | Skip to navigation

News

Innovative treatment for inflammatory eye condition recommended for use on the NHS

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Innovative treatment for inflammatory eye condition recommended for use on the NHS

People with recurrent non-infectious uveitis affecting the back of the eye could benefit from a new treatment option, the fluocinolone acetonide implant, as a result of new NICE guidance published this week.

The treatment, which is injected into the eye, lasts 3 years. This could mean fewer hospital visits for patients who receive current treatments: including corticosteroid injections, immunosuppressants, and dexamethasone and adalimumab implants.

Clinical trial results suggest the fluocinolone acetonide implant may improve clearness of vision for people with uveitis and help prevent the disease returning.